PAYDEN & RYGEL - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 908 filers reported holding NOVARTIS A G in Q1 2017. The put-call ratio across all filers is 2.34 and the average weighting 0.5%.

Quarter-by-quarter ownership
PAYDEN & RYGEL ownership history of NOVARTIS A G
ValueSharesWeighting
Q4 2020$83,000
+9.2%
8760.0%0.00%
-20.0%
Q3 2020$76,000
-1.3%
8760.0%0.01%0.0%
Q2 2020$77,000
+6.9%
8760.0%0.01%0.0%
Q1 2020$72,000
-13.3%
8760.0%0.01%0.0%
Q4 2019$83,000
+9.2%
8760.0%0.01%0.0%
Q3 2019$76,000
-5.0%
8760.0%0.01%0.0%
Q2 2019$80,000
-4.8%
8760.0%0.01%
-16.7%
Q1 2019$84,000
+12.0%
8760.0%0.01%0.0%
Q4 2018$75,0000.0%8760.0%0.01%0.0%
Q3 2018$75,000
+13.6%
8760.0%0.01%
+20.0%
Q2 2018$66,000
-7.0%
8760.0%0.01%
-16.7%
Q1 2018$71,000
-4.1%
8760.0%0.01%0.0%
Q4 2017$74,000
-1.3%
8760.0%0.01%
-14.3%
Q3 2017$75,000
+2.7%
8760.0%0.01%
+16.7%
Q2 2017$73,000
+12.3%
8760.0%0.01%0.0%
Q1 2017$65,000
+1.6%
8760.0%0.01%0.0%
Q4 2016$64,000
-7.2%
8760.0%0.01%
-14.3%
Q3 2016$69,000
-4.2%
8760.0%0.01%
-12.5%
Q2 2016$72,000
+14.3%
8760.0%0.01%0.0%
Q1 2016$63,000
-26.7%
876
-12.4%
0.01%
-27.3%
Q4 2015$86,000
+6.2%
1,000
+14.2%
0.01%
-8.3%
Q3 2015$81,000
-5.8%
8760.0%0.01%
+9.1%
Q2 2015$86,0000.0%8760.0%0.01%0.0%
Q1 2015$86,000
+6.2%
8760.0%0.01%
-26.7%
Q4 2014$81,000
-1.2%
8760.0%0.02%
-6.2%
Q3 2014$82,000
-38.8%
876
-40.7%
0.02%
-52.9%
Q2 2014$134,000
+7.2%
1,4760.0%0.03%
-30.6%
Q1 2014$125,000
+5.0%
1,4760.0%0.05%
+19.5%
Q4 2013$119,000
+5.3%
1,4760.0%0.04%
+2.5%
Q3 2013$113,000
+8.7%
1,4760.0%0.04%
-2.4%
Q2 2013$104,0001,4760.04%
Other shareholders
NOVARTIS A G shareholders Q1 2017
NameSharesValueWeighting ↓
GODSEY & GIBB, INC 184,900$15,121,0006.74%
Martin Investment Management, LLC 289,924$23,710,0005.98%
Camber Capital Management LP 2,000,000$163,560,0005.04%
MANAGED ASSET PORTFOLIOS, LLC 381,778$31,222,0004.76%
PROFESSIONAL ADVISORY SERVICES INC 267,779$21,899,0003.22%
SCHARF INVESTMENTS, LLC 1,244,711$101,794,0003.21%
GARLAND CAPITAL MANAGEMENT INC 50,755$4,151,0002.97%
First Fiduciary Investment Counsel, Inc. 167,378$13,688,0002.67%
WILKINS INVESTMENT COUNSEL INC 130,590$10,680,0002.61%
Lowell Blake & Associates Inc. 66,309$5,423,0002.52%
View complete list of NOVARTIS A G shareholders